Corcept Gains Positive CHMP Opinion for Lifyorli in Ovarian Cancer
REDWOOD CITY, Calif. — September 18, 2026 Corcept Therapeutics announced that the European Medicines Agency’s Committee for Medicinal Products...
EMA
Advertisement
Daiichi Sankyo and AstraZeneca Gain EU Backing for Enhertu
TOKYO — September 18, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products...
Johnson & Johnson Wins EU Approval for ICOTYDE in Psoriasis
Beerse, Belgium, September 21, 2026 Johnson & Johnson has reached a major European regulatory milestone with the European Commission’s...
Arcturus to Present ARCT-810 Phase 2 OTC Deficiency Data
SAN DIEGO — September 18, 2026 Arcturus Therapeutics announced plans to provide an update on its ARCT-810 Phase 2...
Beacon Therapeutics Reports Positive VISTA Data for Laru-zova
LONDON and CAMBRIDGE, Mass September 21, 2026 — Beacon Therapeutics announced positive topline results from the pivotal VISTA trial...
Advertisements
Merck Gains Positive EU CHMP Opinion for KEYTRUDA and Padcev
RAHWAY, N.J. — September 18, 2026 Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
IMPACT Therapeutics Gains Positive CHMP Opinion for Senaparib
NANJING, China and BASILDON, UK — September 18, 2026 IMPACT Therapeutics and Pharmanovia announced that the Committee for Medicinal...
Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA
MILAN, Italy — September 18, 2026 Alfasigma announced that the Committee for Medicinal Products for Human Use (CHMP) of...
Zealand Pharma Gains Positive CHMP Opinion for Zeydovio
Zealand Pharma Gains Positive CHMP Opinion for Zeydovio Zealand Pharma announced that the Committee for Medicinal Products for Human...
Novartis Advances Cosentyx for Polymyalgia Rheumatica
Basel, Switzerland, September 18, 2026 Novartis has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Advertisement
